Skip to main content
. 2015 Aug 24;33(31):3635–3640. doi: 10.1200/JCO.2014.59.9258

Table 1.

Key Patient Characteristics

graphic file with name zlj03115-5528-t01.jpg

Characteristic L Arm (n = 45)
LR Arm (n = 46)
No. of Patients % No. of Patients %
Age, years
    Median 63 64
    Range 34-85 36-89
FLIPI 36 35
    Low 33.3 51.4
    Intermediate 41.7 28.6
    High 25.0 20.0
TTP since last R dose, years 1.6 1.4
Stage 45 45
    I/II 22.3 33.4
    III/IV 77.8 66.7
LDH 44 44
    > NL 15.9 2.3

Abbreviations: FLIPI, Follicular Lymphoma International Prognostic Index; L, lenalidomide; LDH, lactate dehydrogenase; LR, lenalidomide plus rituximab; NL, normal limit; R, rituximab; TTP, time to progression.